To study different levels of MK0493 for safety, efficacy, and tolerability in obese patients

Trial Profile

To study different levels of MK0493 for safety, efficacy, and tolerability in obese patients

Completed
Phase of Trial: Phase II

Latest Information Update: 13 May 2014

At a glance

  • Drugs MK 0493 (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 01 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top